A novel method for detecting IgA endomysial antibodies by using human umbilical vein endothelial cells
- PMID: 10656209
- DOI: 10.1097/00042737-200012010-00009
A novel method for detecting IgA endomysial antibodies by using human umbilical vein endothelial cells
Abstract
Background: Although tissue transglutaminase was recently identified as the main autoantigen recognized by endomysial antibodies in coeliac patients, anti-endomysium antibody detection still persists as the gold standard for coeliac disease screening and diagnosis.
Objectives: (1) To evaluate human umbilical vein cells (HUVEC) as an alternative source of endomysial antigen and to assess their suitability in the diagnosis of coeliac disease. (2) To verify whether tissue transglutaminase is one target antigen eliciting the endomysial antibody fraction of coeliac serum IgA.
Setting: University teaching hospital.
Patients and methods: Sera from 123 untreated adults with biopsy-proven coeliac disease and 84 controls (40 healthy and 44 diseased) were assessed by indirect immunofluorescence, using HUVEC on glass slides prepared by cytocentrifugation and permeabilized by using Triton X (0.5%). Indirect immunofluorescence was performed: (1) using coeliac disease serum samples on HUVEC with or without prior incubation with tissue transglutaminase; and (2) incubating both HUVEC and monkey oesophagus with goat anti-guinea pig tissue transglutaminase antibody.
Results: All the coeliac patients, who were also positive on monkey oesophagus, showed the typical fluorescent homogeneous cytoplasmic stain on HUVEC. All control sera were negative both on HUVEC and on monkey oesophagus. IgA antibodies did not react with non-permeabilized cells, with intact membrane. Preincubation of coeliac sera with tissue transglutaminase abolished the typical fluorescent pattern. The incubation of anti-tissue transglutaminase antibody with monkey oesophagus and HUVEC resulted in an immunofluorescence staining pattern identical to that obtained with positive coeliac sera.
Conclusions: (1) As a substrate for anti-endomysial antibody, HUVEC may provide the same diagnostic accuracy as monkey oesophagus, thus bypassing economical and ethical problems. The HUVEC antigen reacting with IgA from coeliac disease sera is an intracellular rather than a cell-surface antigen, as IgA antibodies reacted only with permeabilized cells. (2) Pretreatment of untreated coeliac sera with tissue transglutaminase abolished almost completely the specific staining; incubation with anti-tissue transglutaminase antibody elicited the characteristic fluorescent pattern, thus confirming that tissue transglutaminase represents the prominent autoantigen in coeliac disease.
Similar articles
-
Transglutaminase and coeliac disease: endomysial reactivity and small bowel expression.Clin Exp Immunol. 1999 Dec;118(3):371-5. doi: 10.1046/j.1365-2249.1999.01054.x. Clin Exp Immunol. 1999. PMID: 10594554 Free PMC article.
-
Anti-transglutaminase antibodies and coeliac disease.Aust N Z J Med. 1999 Apr;29(2):239-42. doi: 10.1111/j.1445-5994.1999.tb00690.x. Aust N Z J Med. 1999. PMID: 10342024 Clinical Trial.
-
Human umbilical vein endothelial cells: a new easily available source of endomysial antigens.Eur J Gastroenterol Hepatol. 1996 Oct;8(10):961-6. doi: 10.1097/00042737-199610000-00005. Eur J Gastroenterol Hepatol. 1996. PMID: 8930559
-
IgA anti-tissue transglutaminase: setting the stage for coeliac disease screening.Eur J Gastroenterol Hepatol. 2001 Jun;13(6):635-7. doi: 10.1097/00042737-200106000-00004. Eur J Gastroenterol Hepatol. 2001. PMID: 11434587 Review.
-
Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.Gastroenterology. 2017 Sep;153(3):689-701.e1. doi: 10.1053/j.gastro.2017.05.015. Epub 2017 May 22. Gastroenterology. 2017. PMID: 28545781 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous